701
Views
3
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism

&
Pages 313-320 | Received 08 Jan 2019, Accepted 27 Mar 2019, Published online: 08 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrés Muñoz, Enrique Gallardo, Giancarlo Agnelli, Carlos Crespo, Monica Forghani, Daniel Arumi, Susana Fernández de Cabo & Javier Soto. (2022) Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain. Journal of Medical Economics 25:1, pages 840-847.
Read now
Tarek Ajam, Tabitha L Cumpian, Blair L Tilkens, Imaan A Jahangir, Jared Frost, Cheryl Ceretto & Arshad Jahangir. (2020) Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. Expert Review of Clinical Pharmacology 13:12, pages 1309-1327.
Read now

Articles from other publishers (1)

Kaidireyahan Wumaier, Wenqian Li, Naifei Chen & Jiuwei Cui. (2021) Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis. Thrombosis Journal 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.